317 related articles for article (PubMed ID: 33171402)
1. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.
Reina-Couto M; Afonso J; Carvalho J; Morgado L; Ronchi FA; de Oliveira Leite AP; Dias CC; Casarini DE; Bettencourt P; Albino-Teixeira A; Morato M; Sousa T
Biomed Pharmacother; 2021 Jan; 133():110938. PubMed ID: 33171402
[TBL] [Abstract][Full Text] [Related]
2. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
3. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
4. The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes.
Burns KD; Lytvyn Y; Mahmud FH; Daneman D; Deda L; Dunger DB; Deanfield J; Dalton RN; Elia Y; Har R; Van JA; Bradley TJ; Slorach C; Hui W; Xiao F; Zimpelmann J; Mertens L; Moineddin R; Reich HN; Sochett E; Scholey JW; Cherney DZ
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F335-F342. PubMed ID: 27733369
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
Tiryaki Ö; Usalan C; Sayiner ZA
Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
[TBL] [Abstract][Full Text] [Related]
6. Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?
Persson F; Lu X; Rossing P; Garrelds IM; Danser AH; Parving HH
J Hypertens; 2013 Aug; 31(8):1646-52. PubMed ID: 23743807
[TBL] [Abstract][Full Text] [Related]
7. Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.
Kim H; Park S; Jhee JH; Yun HR; Park JT; Han SH; Lee J; Kim SW; Kim YH; Oh YK; Kang SW; Choi KH; Yoo TH;
BMC Nephrol; 2019 Mar; 20(1):104. PubMed ID: 30909873
[TBL] [Abstract][Full Text] [Related]
8. Independent regulation of renin-angiotensin-aldosterone system in the kidney.
Nishiyama A; Kobori H
Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408
[TBL] [Abstract][Full Text] [Related]
9. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
[TBL] [Abstract][Full Text] [Related]
10. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease.
Miller M; Quimby J; Langston C; Ames M; Parker VJ
J Vet Intern Med; 2022 Sep; 36(5):1693-1699. PubMed ID: 35962709
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
[TBL] [Abstract][Full Text] [Related]
14. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
15. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
[TBL] [Abstract][Full Text] [Related]
16. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
[TBL] [Abstract][Full Text] [Related]
17. Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism.
Vergaro G; Fatini C; Sticchi E; Vassalle C; Gensini G; Ripoli A; Rossignol P; Passino C; Emdin M; Abbate R
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):416-22. PubMed ID: 25036270
[TBL] [Abstract][Full Text] [Related]
18. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.
Remuzzi G; Perico N; Macia M; Ruggenenti P
Kidney Int Suppl; 2005 Dec; (99):S57-65. PubMed ID: 16336578
[TBL] [Abstract][Full Text] [Related]
19. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
Mewton N; Girerd N; Boffa JJ; Courivaud C; Isnard R; Juillard L; Lamblin N; Legrand M; Logeart D; Mariat C; Meune E; Sabouret P; Sebbag L; Rossignol P
Arch Cardiovasc Dis; 2020 Oct; 113(10):660-670. PubMed ID: 32660835
[TBL] [Abstract][Full Text] [Related]
20. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
